"10.1371_journal.pone.0080008","plos one","2013-11-11T00:00:00Z","Gunnveig Gr√∏deland; Siri Mjaaland; Gro Tunheim; Agnete B Fredriksen; Bjarne Bogen","Institute of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway; K.G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway; Centre for Immune Regulation (CIR), University of Oslo and Oslo University Hospital, Oslo, Norway; Division for Infectious Disease Control, Department of Bacteriology and Infection Immunology, Norwegian Institute of Public Health, Oslo, Norway","Conceived and designed the experiments: GG SM ABF BB. Performed the experiments: GG SM. Analyzed the data: GG SM. Wrote the paper: GG BB. Prepared the first HA-encoding fusion vaccine from HAwt-pCMV: GT. Edited and commented on the paper: GG SM GT ABF BB.","The authors have read the journals policy and have the following conflicts. BB, ABF and GG are inventors on patent applications filed on the vaccine molecules by the TTO offices of the University of Oslo and Oslo University Hospital, according to institutional rules (US 2004/0253238 A1: Modified Antibody; 61538,186: Vaccibodies targeting to cross-presenting dendritic cells). BB is head of the Scientific panel, and ABF was at the time part-time CSO of the Vaccibody company. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","11","Gunnveig Gr√∏deland","GG√",5,TRUE,4,2,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
